Trump confirms Makary out at FDA
President Donald Trump confirmed on Tuesday that Marty Makary would be leaving his post atop the U.S. Food and Drug Administration.
While speaking to reporters on the White House lawn Tuesday, Trump said Makary would be leaving. He said FDA deputy commissioner Kyle Diamantes will take over as the adminsitration seeks a new leader of the federal agency.
“He was having some difficulty,” Trump said. “Marty is a terrific guy, but he’s going to go and lead a good life.”
Trump did not specify what kind of difficulty Makary experienced. Several reports circulated that there was an internal dispute over approval for flavored vapes at the FDA. The Wall Street Journal reported that Trump pressured Makary to approve fruit-flavored vapes, but he was hesitant to do so.
Trump said many people are seeking the job atop the agency.
Makary was expected to testify on Capitol Hill Wednesday to present the FDA’s budget for the upcoming fiscal year. Diamantes is expected to take his place.
Makary was confirmed to lead the FDA in March 2025. Since then, he’s sought to make several changes to the agency’s policies and change organizational structure. Makary sought to limit antidepressants for pregnant women and ban kratom byproducts.
“He’s a friend of mine, he’s a wonderful man and he’s going to be off,” Trump said of Makary.
Latest News Stories
Congress returns to backlog of must-pass legislation
Climate science without a notorious worst-case scenario
Beecher Trustee Warns of State Bills That Could Strip Local Zoning Control
Illinois Quick Hits: Housing, megaprojects take backseat to budget talks
Taxpayer watchdog calls for accountability after helicopter prom controversy
Proposed $250 bill could be a boon for drug cartels, experts warn
Iowa voters head to the polls for fierce races
Speakers object to transgender athletes in girls sports
Taxpayers group, economist praise Pratt’s plan for homelessness in LA
Almost 25,000 immigration arrests made in Florida
Illinois Quick Hits: Unemployment numbers rise; Champaign job growth continues
Filing lawsuits doesn’t immunize Gori vs asbestos fraud claims: New filing